Patent US5705337A successfully refreshed from Google Patents.
US5705337A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
Assignee: Gilead Sciences Inc
•
Filing: 1995-03-08
•
Granted: 1998-01-06
•
Expires: 2015-03-08
Abstract
Abstract This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
Inventors
- 👤 Larry Gold
- 👤 Bruce Eaton
- 👤 Drew Smith
- 👤 Matthew Wecker
- 👤 Kirk Jensen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 17:44
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/76; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/547; A61K47/549; B; B82; B82Y; B82Y5/00; C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H21/00; C07K; C07K14/00; C07K14/001; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1034; C12N15/1048; C12N15/11; C12N15/115; C12N9/00; C12N9/10; C12N9/12; C12N9/1241; C12N9/1276; C12Q; C12Q1/00; C12Q1/34; C12Q1/37; C12Q1/68; C12Q1/6811; G01N33/53; G01N33/531; G01N33/532; G01N33/535; G01N33/569; G01N33/56983; G01N33/56988; G01N33/68; C12N2310/00; C12N2310/10; C12N2310/13; C12N2310/30; C12N2310/32; C12N2310/322; C12N2310/50; C12N2310/53; C40; C40B; C40B40/00; F; F02; F02B; F02B75/00; F02B75/02; F02B2075/022; F02B2075/027; G01N2333/00; G01N2333/005; G01N2333/08; G01N2333/15; G01N2333/155; G01N2333/16; G01N2333/163; G01N2333/435; G01N2333/575; G01N2333/62; G01N2333/81; G01N2333/8107; G01N2333/811; G01N2333/8121; G01N2333/8125; G01N2333/90; G01N2333/914; G01N2333/948; G01N2333/95; G01N2333/964; G01N2333/96425; G01N2333/96427; G01N2333/9643; G01N2333/96433; G01N2333/96436; G01N2333/96441; G01N2333/96455; G01N2333/96486; G01N2333/966; G01N2333/972; G01N2333/9726; G01N2333/974; G01N2333/976
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
98 words
A method for identifying nucleic acid ligands that bind covalently with a target molecule from a candidate mixture of nucleic acids wherein each nucleic acid in said candidate mixture comprises a chemically reactive functional unit, said method comprising: a) preparing a candidate mixture of said nucleic acids; b) contacting said candidate mixture with said target molecule, wherein nucleic acids which bind covalently with said target molecule form nucleic acid-target molecule complexes; c) partitioning the nucleic acid-target molecule complexes from the remainder of the candidate mixture, whereby nucleic acid ligands that bind covalently with the target molecule are identified.
Claim 2
Independent Claim
98 words
A method for identifying nucleic acid ligands that bind covalently with a target molecule from a candidate mixture of nucleic acids wherein each nucleic acid in said candidate mixture comprises a chemically reactive functional unit, said method comprising: a) preparing a candidate mixture of said nucleic acids; b) contacting said candidate mixture with said target molecule, wherein nucleic acids which bind covalently with said target molecule form nucleic acid-target molecule complexes; c) partitioning the nucleic acid-target molecule complexes from the remainder of the candidate mixture, whereby nucleic acid ligands that bind covalently with the target molecule are identified.
Claim 3
Dependent Claim
38 words
The method of claim 1 wherein after step c), the nucleic acid is amplified and steps b) through c) repeated until a mixture of nucleic acids enriched in sequences that bind covalently with the target molecule is obtained.
Claim 4
Dependent Claim
26 words
The method of claim 1 wherein said chemically reactive functional unit is selected from the group consisting of photoreactive groups, active site directed compounds and peptides.
Claim 5
Dependent Claim
27 words
The method of claim 1 wherein the target is modified to include a chemical moiety that reacts with the chemically reactive functional unit of the nucleic acid.
Claim 6
Dependent Claim
17 words
The method of claim 1 wherein said nucleic acid comprises a fixed region and a randomized region.
Claim 7
Dependent Claim
21 words
The method of claim 5 wherein said chemically reactive functional unit is attached to an oligonucleotide hybridized to said fixed region.
Claim 8
Dependent Claim
20 words
The method of claim 1 wherein said target is selected from the group consisting of bradykinin, elastase, and HIV-1 Rev.
References Cited (Backward Citations)
US4959309A
Cited
GB2183661A
Cited
WO1989006694A1
Cited
WO1991014696A1
Cited
WO1991019813A1
Cited
US5270163A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-01-05 | 2001-07-07 | 2002-01-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-01-05 | 2005-07-07 | 2006-01-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-01-05 | 2009-07-07 | 2010-01-06 | $7700.00 | Window Closed / Lapsed |